Shopping Cart 0
Cart Subtotal
USD 0

University of Illinois - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

University of Illinois (UOL) is a university that offers undergraduate, graduate, and professional programs. The university offers online and continuing education programs such as undergraduate and graduate online degrees. It provides research activities in the areas of alternative, complementary and traditional medicine; biotechnology and biodefense; cancer biology and therapeutics; drug discovery, development and delivery; infectious diseases; natural products; neuroscience; patient safety; and pharmacoeconomics. The university offers courses through the College of Agricultural, Consumer and Environmental Sciences; College of Applied Health Sciences; Institute of Aviation; College of Business; College of Education; College of Engineering; and College of Fine and Applied Arts, among others. UOL is headquartered in Urbana, Illinois, the US.

University of Illinois-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

University of Illinois, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Illinois, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Illinois, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Illinois, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Illinois, Medical Devices Deals, 2012 to YTD 2018 10

University of Illinois, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

University of Illinois, Pharmaceuticals & Healthcare, Deal Details 12

Licensing Agreements 12

Revivo Therapeutics Receives Technology Rights from University of Illinois and Queens University 12

Ocugen Enters into Licensing Agreement with University of Illinois at Chicago 13

Revolution Medicines Enters into Licensing Agreement with University of Illinois 14

Actuate Therapeutics Enters into Licensing Agreement with University of Illinois at Chicago and Northwestern University 15

Cortex Pharma Enters into Licensing Agreement with University of Illinois 16

zuChem Enters Into Licensing Agreement With University Of Illinois At Urbana-Champaign 18

University Of Illinois And University Of Texas Enter Into Licensing Agreement With StemPar Sciences For Anti-Cancer Compounds 19

Sigma-Aldrich Enters Into Licensing Agreement With University of Illinois 20

Equity Offering 21

ResQ Pharma Spins Out from University of Illinois 21

University of Illinois-Key Competitors 22

University of Illinois-Key Employees 23

University of Illinois-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 26

Government and Public Interest 26

Sep 20, 2018: Smart pills dumb down medical care, experts warn 26

Sep 04, 2018: UIC to lead study of negative pressure wound therapy in obese and diabetic patients 28

Aug 16, 2018: New CRISPR technique skips over portions of genes that can cause disease 29

Aug 01, 2018: Nowhere to hide: Molecular probe illuminates elusive cancer stem cells in live mice 31

Jul 30, 2018: Magnetic nanoparticles deliver chemotherapy to difficult-to-reach spinal tumors 32

Jun 21, 2018: DNA enzyme shuffles cell membranes a thousand times faster than its natural counterpart 33

Jun 20, 2018: New tissue-imaging technology could enable real-time diagnostics, map cancer progression 34

Jun 20, 2018: Researchers discover a starring role for chaperone protein Hfq in gene regulation 36

May 21, 2018: New technique can track drug and gene delivery to cells 38

May 07, 2018: New CRISPR technology 'knocks out' yeast genes with single-point precision 39

Mar 12, 2018: Study yields more than a million new cyclic compounds, some with pharmaceutical potential 40

Feb 26, 2018: NIH awards USD 4.6 million for chronic pain research 41

Dec 19, 2017: Unsuspected flexibility offers new pathway to cancer drug development 42

Dec 07, 2017: Quick evaluation can predict whether drugs, talk therapy work better for anxiety patients 44

Nov 27, 2017: Stem cells in intestinal lining may shed light on behavior of cancer cells 46

Nov 06, 2017: Stem cells from muscle could address diabetes-related circulation problems 48

Jul 17, 2017: Epilepsy biomarkers pave way for noninvasive diagnosis, better treatments 50

Feb 14, 2017: Tumor-targeting system uses cancer's own mechanisms to betray its location 51

Product News 52

Nov 27, 2017: Drug-delivering nanoparticles seek and destroy elusive cancer stem cells 52

Feb 12, 2018: Tiny drug-delivering capsules could sustain transplanted insulin-producing cells for diabetics 53

Appendix 54

Methodology 54

About GlobalData 54

Contact Us 54

Disclaimer 54


List Of Figure

List of Figures

University of Illinois, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Illinois, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Illinois, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Illinois, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Illinois, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Illinois, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

University of Illinois, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Illinois, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Illinois, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

University of Illinois, Pharmaceuticals & Healthcare, Key Facts 2

University of Illinois, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Illinois, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Illinois, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Illinois, Deals By Therapy Area, 2012 to YTD 2018 9

University of Illinois, Medical Devices Deals, 2012 to YTD 2018 10

University of Illinois, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Revivo Therapeutics Receives Technology Rights from University of Illinois and Queens University 12

Ocugen Enters into Licensing Agreement with University of Illinois at Chicago 13

Revolution Medicines Enters into Licensing Agreement with University of Illinois 14

Actuate Therapeutics Enters into Licensing Agreement with University of Illinois at Chicago and Northwestern University 15

Cortex Pharma Enters into Licensing Agreement with University of Illinois 16

zuChem Enters Into Licensing Agreement With University Of Illinois At Urbana-Champaign 18

University Of Illinois And University Of Texas Enter Into Licensing Agreement With StemPar Sciences For Anti-Cancer Compounds 19

Sigma-Aldrich Enters Into Licensing Agreement With University of Illinois 20

ResQ Pharma Spins Out from University of Illinois 21

University of Illinois, Key Competitors 22

University of Illinois, Key Employees 23

University of Illinois, Subsidiaries 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

University of Illinois, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.